These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37387837)

  • 1. Retracted: Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9764769. PubMed ID: 37387837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Efficacy and Safety of Peginterferon
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9895013. PubMed ID: 37520039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Effects of Tenofovir Combined with Recombinant Human Interferon
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2022; 2022():9791408. PubMed ID: 36482933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Petersen J; Heyne R; Mauss S; Schlaak J; Schiffelholz W; Eisenbach C; Hartmann H; Wiese M; Boeker K; Loehr HF; John C; Leuschner M; Trautwein C; Felten G; Trein A; Krause W; Ruppert S; Warger T; Hueppe D
    Dig Dis Sci; 2016 Oct; 61(10):3061-3071. PubMed ID: 26576555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.
    Kim HJ; Kim JH; Yeon JE; Seo YS; Jang JW; Cho YK; Jang BK; Han BH; Lee C; Lee JH; Yoon JH; Kim KM; Kim MY; Kim DY; Park NH; Cho EY; Lee JS; Lee JW; Kim IH; Song BC; Lee BS; Kwon OS
    J Korean Med Sci; 2022 Mar; 37(11):e92. PubMed ID: 35315603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Clinical Efficacy of PEG-IFN
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9828565. PubMed ID: 37565167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Clinical Diagnostic Value of Quantitative Hepatitis B Virus Core Antibody Test in Chronic Viral Hepatitis B.
    And Applications BC
    Bioinorg Chem Appl; 2023; 2023():9857473. PubMed ID: 37621327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
    Pan CQ; Chan S; Trinh H; Yao A; Bae H; Lou L
    World J Gastroenterol; 2015 May; 21(18):5524-31. PubMed ID: 25987775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
    Agarwal K; Brunetto M; Seto WK; Lim YS; Fung S; Marcellin P; Ahn SH; Izumi N; Chuang WL; Bae H; Sharma M; Janssen HLA; Pan CQ; Çelen MK; Furusyo N; Shalimar D; Yoon KT; Trinh H; Flaherty JF; Gaggar A; Lau AH; Cathcart AL; Lin L; Bhardwaj N; Suri V; Mani Subramanian G; Gane EJ; Buti M; Chan HLY; ;
    J Hepatol; 2018 Apr; 68(4):672-681. PubMed ID: 29756595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B.
    Ibragimov EK; Abdurakhmanov DT; Rozina TP; Nikulkina EN; Tanaschuk EL; Odintsov AV; Panevkina SV; Moiseev SV
    Ter Arkh; 2019 Mar; 91(2):40-47. PubMed ID: 31094170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.
    Berg T; Zoulim F; Moeller B; Trinh H; Marcellin P; Chan S; Kitrinos KM; Dinh P; Flaherty JF; McHutchison JG; Manns M
    J Hepatol; 2014 Apr; 60(4):715-22. PubMed ID: 24295873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Peginterferon
    Yu J; Xu D
    Contrast Media Mol Imaging; 2022; 2022():7623832. PubMed ID: 36247853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine
    Krastev Z; Petrova D; Kotzev I; Celen MK; Mendelson M; Chandra R; Pandey P; Hamed K
    World J Hepatol; 2016 Nov; 8(32):1402-1413. PubMed ID: 27917266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study.
    Chang Y; Kim SG; Jeong SW; Jang JY; Yoo JJ; Lee SH; Kim YS; Kim HS; Lee HW; Park S
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study.
    Lampertico P; Buti M; Fung S; Ahn SH; Chuang WL; Tak WY; Ramji A; Chen CY; Tam E; Bae H; Ma X; Flaherty JF; Gaggar A; Lau A; Liu Y; Wu G; Suri V; Tan SK; Subramanian GM; Trinh H; Yoon SK; Agarwal K; Lim YS; Chan HLY
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):441-453. PubMed ID: 32087795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: a systematic review.
    Zhao SS; Tang LH; Dai XH; Wang W; Zhou RR; Chen LZ; Fan XG
    Virol J; 2011 Mar; 8():111. PubMed ID: 21388525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B.
    Jeong S; Shin HP; Kim HI
    Intervirology; 2022; 65(2):94-103. PubMed ID: 34731856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.
    Kim JH; Jung SW; Byun SS; Shin JW; Park BR; Kim MH; Kim CJ; Park NH
    Int J Clin Pharm; 2015 Dec; 37(6):1228-34. PubMed ID: 26364195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
    Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
    Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
    Marcellin P; Zoulim F; Hézode C; Causse X; Roche B; Truchi R; Pauwels A; Ouzan D; Dumortier J; Pageaux GP; Bourlière M; Riachi G; Zarski JP; Cadranel JF; Tilliet V; Stern C; Pétour P; Libert O; Consoli SM; Larrey D
    Dig Dis Sci; 2016 Oct; 61(10):3072-3083. PubMed ID: 26821154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.